This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| United Kingdom National Cancer Registration and Analysis Service | |
|---|---|
| Name | National Cancer Registration and Analysis Service |
| Type | Public service |
| Jurisdiction | United Kingdom |
| Parent agency | Public Health England |
| Headquarters | England |
| Formed | 2013 |
United Kingdom National Cancer Registration and Analysis Service
The National Cancer Registration and Analysis Service provides population-level cancer registration, analysis, and data services across England, linking clinical, pathological, and administrative records to support cancer control. It operates within a landscape shaped by institutions such as NHS England, Public Health England, Department of Health and Social Care, National Institute for Health and Care Excellence and works alongside research bodies including Cancer Research UK, Wellcome Trust, Medical Research Council, University of Oxford and University College London. The Service informs policy, clinical audit, and academic research by producing datasets used by organizations such as Office for National Statistics, NHS Digital, Royal College of Radiologists, Royal College of Pathologists and World Health Organization.
The Service compiles national cancer incidence, survival, and prevalence metrics used by NHS England, Public Health England, Department of Health and Social Care, Office for National Statistics and World Health Organization for planning, benchmarking, and evaluation. It integrates records from hospitals and registries such as Guy's and St Thomas' NHS Foundation Trust, Royal Marsden NHS Foundation Trust, Addenbrooke's Hospital, Leeds Teaching Hospitals NHS Trust and regional cancer alliances linked to datasets curated by NHS Digital, Clinical Practice Research Datalink, Care Quality Commission and National Institute for Health and Care Excellence. Outputs support guideline bodies like National Institute for Health and Care Excellence, audit programmes by Royal College of Surgeons, and trial groups including National Institute for Health Research and Cancer Research UK.
Origins trace to early cancer registration efforts connected to institutions such as Statens Serum Institut, International Agency for Research on Cancer, Office for National Statistics, MRC Epidemiology Unit, and regional registries in the 20th century alongside work at University of Oxford, University of Cambridge, London School of Hygiene & Tropical Medicine and Kings College London. The modern Service was established within Public Health England in 2013 following reorganization influenced by policies from the Department of Health and Social Care, reviews by Academy of Medical Sciences, and collaborations with Cancer Research UK and Wellcome Trust. Subsequent developments involved integration with national datasets held by NHS Digital, implementation of standards from International Agency for Research on Cancer, and partnerships with academic centres such as University College London, Imperial College London and University of Manchester.
Governance aligns with structures in Public Health England, oversight from Department of Health and Social Care, and accountability to statutory bodies including NHS England and Office for National Statistics. Operational units liaise with clinical networks like Cancer Alliances, hospital trusts such as Royal Marsden NHS Foundation Trust and research funders including National Institute for Health Research, Cancer Research UK and Medical Research Council. Advisory links exist with professional colleges such as Royal College of Physicians, Royal College of Surgeons, Royal College of Pathologists and regulatory bodies like Care Quality Commission to ensure alignment with clinical standards, ethics frameworks from Health Research Authority and reporting conventions adopted by World Health Organization.
Data collection sources include hospital episode statistics from NHS Digital, pathology reports from trusts such as Royal Marsden NHS Foundation Trust, screening records from programmes like NHS Breast Screening Programme and death registrations from Office for National Statistics. The Service maintains national registries aligned with classifications used by International Agency for Research on Cancer, staging systems endorsed by Union for International Cancer Control, and coding standards employed by World Health Organization and Office for National Statistics. Linkage activities connect datasets from Clinical Practice Research Datalink, trial cohorts funded by Medical Research Council and biobanks such as UK Biobank to enable research with partners like University College London, University of Oxford and Imperial College London.
Analytical outputs contribute to publications in journals read by audiences at National Institute for Health and Care Excellence, Royal College of Radiologists, European Society for Medical Oncology and academic departments at University of Cambridge, University of Edinburgh, King's College London and University of Glasgow. Collaborative research spans survival analysis used by Office for National Statistics, audits for Royal College of Surgeons, and epidemiological studies linked to International Agency for Research on Cancer, with funding from Medical Research Council, Wellcome Trust and Cancer Research UK. The Service’s reports inform guideline development by National Institute for Health and Care Excellence and policy reviews conducted by Department of Health and Social Care.
Data access policies follow legal frameworks involving Health Research Authority, Information Commissioner's Office, NHS England and ethical review processes used by Research Ethics Committees. Safeguards reflect standards advocated by World Health Organization, data governance models from NHS Digital, and transparency expectations put forward by Office for National Statistics and funders such as Wellcome Trust and Medical Research Council. Agreements for research access involve institutions like University College London, University of Oxford and commercial partners operating under oversight from Care Quality Commission and ethical committees convened through Health Research Authority.
The Service’s analyses have influenced screening policy reviews by NHS England, guideline updates by National Institute for Health and Care Excellence, cancer strategy documents from Department of Health and Social Care and resource planning by NHS England. Outputs support quality assurance in centres such as Royal Marsden NHS Foundation Trust and inform national targets reported to Office for National Statistics and international comparisons coordinated with World Health Organization and International Agency for Research on Cancer. Its data underpin evaluations funded by National Institute for Health Research and advocacy conducted by Cancer Research UK.
International engagement includes alignment with standards from International Agency for Research on Cancer, participation in benchmarking with registries like Surveillance, Epidemiology, and End Results Program, collaborations with agencies such as World Health Organization, and methodological exchanges with institutions like European Cancer Observatory, Statens Serum Institut and university groups at Harvard University, University of Toronto and University of Melbourne. These partnerships support harmonisation of classification systems endorsed by Union for International Cancer Control and reporting frameworks used by Office for National Statistics and World Health Organization.